Dear all,
We are pleased to announce the 3rd edition of the Swiss RNA Therapeutics Summit, which will be held on January 23, 2025, at the University of Bern.
Link to the current program. Link to the list of current speakers & panelists. Link to registration.
Three keynotes will be delivered by:
Mathias Vormehr – Senior Director Cancer Vaccines – BioNTech, Mainz, Germany
“mRNA vaccines for the treatment of cancer”
Annemieke Aartsma-Rus – Professor of Human Genetics – University of Leiden, Netherlands
“From Duchenne exon skipping to N=1 treatment: Applying lessons learned for (very) rare disease patients”
Eric Miska – Co-founder Storm Therapeutics & Professor, University of Cambridge, United Kingdom
“New ways of targeting and delivering RNA”
The keynotes are program-wise complemented by Company Presentations, Talks on Translational Academic Projects & Clinical RNA Therapeutics in Rare Diseases, a panel on Medical Development, and Young Scientists Career Talks, during which alumni from Swiss Universities in the field of RNA research will present in very short talks their career paths and current position.
A poster session will be held during lunch for which abstracts can be submitted. Please note you can register for the event and submit the poster abstract later.
Link to the current program. Link to the list of current speakers & panelists. Link to registration.
Also, registered participants can opt-in to exchange messages with other participants who opted in before the conference using the conference registration system.
The regular attendance rate is 150 CHF, the discounted rate is 100 CHF, and the rate for students, PhD students, and postdocs from Swiss Universities is 40 CHF. Check the registration site for more details.
@MSc Students, PhD Students & Postdocs: We are looking for helpers for tasks during the conference e.g. microphone running, slides loading etc.. If you would like to help with such a task and in return get free registration to the event, please write to: dominik.theler@bc.biol.ethz.ch
We are delighted to announce that Sonja Merkas has joined the organizing team for the Swiss RNA Therapeutics Summit. She holds a PhD in Chemistry and was a postdoctoral fellow at ETH Zurich. With 25 years of experience across the life science sector, including industry, consulting and academia, she brings a wealth of expertise in the RNA field to our team. Together with Jonathan Hall, Ramesh Pillai and Dominik Theler, Sonja Merkas will bring her expertise to support the ongoing success of the Swiss RNA Therapeutics Summit.